Hutchison China MediTech Limited (HCM) Social Stream
HUTCHMED (CHINA) LTD (HCM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering HUTCHMED (CHINA) LTD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-20 | 4 | $52 | $40.3 | $47.575 | $13.03 | 265.12% |
| 2022-03-10 | 4 | $52 | $46.25 | $49.062 | $13.03 | 276.53% |
| 2022-03-16 | 4 | $52 | $30.35 | $45.087 | $13.03 | 246.02% |
| 2022-05-02 | 4 | $50 | $22 | $36.837 | $13.03 | 182.71% |
| 2022-06-08 | 5 | $50 | $22 | $36.837 | $13.03 | 182.71% |
| 2022-08-02 | 5 | $50 | $20.25 | $34.312 | $13.03 | 163.33% |
| 2022-08-08 | 6 | $50 | $14 | $30.25 | $13.03 | 132.16% |
| 2022-08-13 | 6 | $50 | $16 | $30.65 | $13.03 | 135.23% |
The Trend in the Analyst Price Target
Over the past 21 months, HCM's average price target has gone down $7.12.
HCM reports an average of 138.13% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-20 | 3 | 52 | 40.30 | 47.575 | 38.18 | 24.61% |
| 2022-01-18 | 4 | 52 | 46.25 | 49.062 | 30.54 | 60.65% |
| 2022-03-04 | 4 | 52 | 46.25 | 49.062 | 21.57 | 127.45% |
| 2022-05-02 | 4 | 50 | 22.00 | 36.837 | 12.23 | 201.2% |
| 2022-08-02 | 6 | 50 | 20.25 | 34.312 | 11.89 | 188.58% |
HCM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 4 | 0 | 2 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 30 weeks, HCM's average broker recommendation rating worsened by 0.67.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HCM as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, HUTCHMED (CHINA) LTD's upside potential (average analyst target price relative to current price) is greater than 825.97% of them.
- In the context of all US stocks, HUTCHMED (CHINA) LTD's variance in analysts' estimates is lower than -535.28% of them.
- In the context of stocks in the mid market cap category, HUTCHMED (CHINA) LTD's number of analysts covering the stock is higher than 230.89% of them.
- In terms of how HUTCHMED (CHINA) LTD fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 623.55% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to HUTCHMED (CHINA) LTD are GBT, FOLD, and FGEN.
View All Top Stocks by Price Target
What is the outlook for HCM? Use POWR Ratings for clearer insight into price direction.